mifepristone

(redirected from Korlym)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to Korlym: Mifepristone, Signifor

mi·fep·ri·stone

 (mĭ-fĕp′rĭ-stōn′)
n.
A synthetic steroid, C29H35NO2, that blocks the action of progesterone and is used in combination with misoprostol to induce abortion in early pregnancy. Also called RU 486.

[(a)mi(no) + alteration of phe(nyl) + pr(opyl) + alteration of est(radiol) + -one.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

mifepristone

(mɪˈfɛprɪˌstəʊn)
n
(Pharmacology) an antiprogestogenic steroid, used in the medical termination of pregnancy. Formula: C29H35NO2
[C20: from aminophenol + propyne + oestradiol + -one]
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

mif•e•pris•tone

(ˌmɪf əˈprɪs toʊn)
n.
an antigestational drug that prevents a fertilized egg from attaching to the uterine wall by blocking the action of progesterone.
[1985–90; probably alter. of (a)mi(no)phe(nol) + pr(opyl) + est(radiol) + -one]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.mifepristone - an abortion-inducing drug (trade name RU_486) developed in Francemifepristone - an abortion-inducing drug (trade name RU_486) developed in France; when taken during the first five weeks of pregnancy it blocks the action of progesterone so that the uterus sloughs off the embryo
aborticide, abortifacient, abortion-inducing drug - a drug (or other chemical agent) that causes abortion
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

mifepristone

n mifepristona
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Corcept's approved product, Korlym, was the first treatment approved by the U.S.
In a regulatory filing, Corcept Therapeutics reported that it is disseminating a white paper entitled "Some Important Facts about Corcept, Physicians and Patients." The white paper states in part: "Our FDA-approved medication, Korlym, has saved the lives of some patients and greatly improved the health of many more.
Newer medical treatments, for example, Novartis' Signifor (pasireotide) and Corcept Therapeutics' Korlym (mifepristone) address only some of these issues; yet, present their own limitations.
Net proceeds from the warrant exercise and the offering will be used by the company to fund its ongoing operations, the commercialisation of Korlym 300 mg tablets, continuation of its Phase III clinical trial of mifepristone for psychotic depression, further development of next-generation compounds, fund working capital and for general corporate purposes.
M2 PHARMA-February 20, 2012-Corcept Therapeutics Incorporated receives FDA approval of Korlym 300 mg tablets for patients with Cushinga[euro](tm)s Syndrome(C)2012 M2 COMMUNICATIONS